In many countries, maintenance hemodialysis (MHD) is the main renal replacement therapy for patients with end-stage kidney disease. Abnormal functioning of hemodialysis (HD) vascular access is one of ...

A retrospective review of the pharmacy computer database was performed to identify hemodialysis patients with central venous catheters who received alteplase or urokinase for presumed catheter ...

A two-phase multicenter prospective randomized study followed the pilot trial. The purpose of the multicenter randomized trial was to compare the efficacy and safety of the LifeSite system with a ...

Researchers at Okayama University report in The Journal of Vascular Access a supporting device for accurately placing hemodialysis catheters on kidney patients. The device was successfully used on a ...

VANCOUVER, Aug. 29 - Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, today announced that the U.S. Food and Drug Administration (FDA) has given ...

Please provide your email address to receive an email when new articles are posted on . Two randomized trials reported discordant intervention effects. Results highlight a need for further study to ...

Angiotech Pharmaceuticals, Inc., of Vancouver, Canada, has been given clearance to market the Hemo-Stream chronic dialysis catheter, the first device of its kind specifically designed for ...

The use of sutureless securement devices during catheterization might reduce the risk of catheter-related bloodstream infection (CRBSI) by suppressing catheter-exit infection and catheter dislodgement ...